Aller au contenu

Interactions médicamenteuses

Lorlatinib + Mitotane

Gravité: Contre-indiquée

Lorlatinib and Mitotane: contraindicated interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Mitotane is a strong CYP3A4 inducer with a very long half-life, and can markedly lower lorlatinib exposure. This may lead to loss of efficacy and hepatotoxicity.

Ce que signifie cette interaction, en termes simples

Lorlatinib and Mitotane are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Lorlatinib belongs to Oncology; Mitotane belongs to Oncology.

Niveau de preuve: Moderate

Pourquoi elle survient

Mitotane induces CYP3A4 and increases lorlatinib metabolism.

Conduite à tenir

Avoid the combination; because mitotane persists for weeks to months, choose an alternative to lorlatinib or other therapy.

Questions à poser à votre pharmacien

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Lorlatinib et Mitotane, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.

Questions fréquentes

Can I take Lorlatinib with Mitotane?

MediHelp rates the interaction as contraindicated. Lorlatinib and Mitotane are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Mitotane is a strong CYP3A4 inducer with a very long half-life, and can markedly lower lorlatinib exposure. This may lead to loss of efficacy and hepatotoxicity.

How serious is the interaction between Lorlatinib and Mitotane?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; because mitotane persists for weeks to months, choose an alternative to lorlatinib or other therapy.

What other medicines interact with Lorlatinib?

MediHelp also lists interactions of Lorlatinib with, for example, Amobarbital, Apalutamide, Butabarbital. The full list is on the Lorlatinib page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter